Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 12.75 |
| Open | 12.43 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 11.99 - 12.45 |
| 52 Week Range | 1.19 - 14.90 |
| Volume | 243,696 |
| Avg. Volume | 450,626 |
| Market Cap | 893.78M |
| Beta (5Y Monthly) | 1.58 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.87 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- CNW Group
Providence Therapeutics Welcomes Funding from NGen to Bolster COVID-19 Vaccine Manufacturing Capacity
mRNA Vaccine Maker Announced as a First-Round Winner of NGen Strategic Supply ChallengeCALGARY, AB and TORONTO, Jan. 21, 2021 /CNW/ - Providence Therapeutics welcomes today's announcement by Next Generation Manufacturing Canada (NGen) that it has been named as one of eight companies receiving funding to advance its COVID-19 vaccine research and support its manufacturing capacity.
- CNW Group
/R E P E A T -- Invitation to media - Minister Joly to announce investments to support Abitibi-Témiscamingue tourism sector/
AMOS, QC, Jan. 15, 2021 /CNW Telbec/ -Â Canada Economic Development for Quebec Regions (CED)To support organizations in the tourism sector and prepare them for an eventual recovery, the Government of Canada will announce financial assistance in several regions across Quebec on January 18 and 19, 2021.
© 2021 Verizon Media. All rights reserved.
